Psychedelic training is an ‘investment’ in public health: Q&A with UC Berkeley’s Moana Meadow

Moana Meadow, the staff director of the Psychedelic Facilitation Certificate Program at the University of California, Berkeley, talks about the importance of facilitation in cannabis and psychedelic therapies, among other topics.

Mushroom Joe? How President Biden could reschedule psilocybin like marijuana

President Joe Biden or a successor could reschedule psychedelics like marijuana, but only if states create the right psilocybin policies.

Go-to-market strategy for psychedelics diverges from marijuana’s blueprint

The nascent psychedelics industry is taking a different path to market than the marijuana sector, despite their shared medicinal roots.

Israel’s new rules might spur growth in medical cannabis industry

New rules implemented in January by Israel’s Ministry of Health to ease the path for physicians approving medical cannabis – along with further regulatory changes later this year – are expected to spur growth in the nation’s industry, local experts told MJBizDaily.

Kentucky eyes new qualifying conditions for medical marijuana, taps Metrc

Kentucky Gov. Andy Beshear is calling for additional qualifying health conditions for the state’s upcoming medical marijuana program, which would expand the total addressable market for MMJ businesses.

More Republican support needed to pass marijuana banking, Schumer says

Democratic Senate Majority Leader Chuck Schumer says he is still wrangling Republican support for a much-awaited marijuana banking reform bill.

Researchers combine cannabis and psilocybin for medical treatments

Combining cannabinoids with psilocybin into a single formula for treating both physical and mental health issues took another step closer to reality as described in a product patent from a major cannabinoid laboratory, CaaMTech.